Results

Total Results: 801 records

Showing results for "described".

  1. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3w8Wr9wwAyAqUJWmJo_bL-
    February 01, 2014 - Studies of any design were included if they described potential adverse effects, including inaccurate … No studies described adverse effects of the risk models. … No studies described other adverse effects of testing, such as false-positive or false-negative results … Adverse effects were described in a study of annual measurements of serum cancer antigen-125 (CA-125) … Few studies described adverse effects.
  2. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-october-2018
    October 23, 2018 - on elder abuse and abuse of vulnerable adults, this literature is not organized by KQ but is briefly described … accuracy of a tool designed to detect past-year or current overall IPV (not subtypes of abuse only) are described … , provision of an IPV resource sheet) in control groups varied across studies and sometimes was not described … e Usual care described as 2 violence screening questions on clinic intake form and usual clinic protocol … f Usual care described as standard IPV question on intake sheet and referral if IPV was discussed.
  3. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/carotid-artery-stenosis-screening-july-2014
    July 08, 2014 - Benefits of CEA or CAAS Beyond Medical Therapy We included 3 RCTs ( Table 1 0 described in 12 publications … 32–43 that compared CEA with medical therapy and 3 systematic reviews described in 5 publications … Characteristics Randomized, controlled trials that compared CEA with medical therapy have been described … reflect the published literature, and most key issues limiting applicability of the evidence have been described
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/gRNjNsmqZvBC-DnHGRMgG3
    December 01, 2014 - METHODS Methods are further described in a technical report (13). … Studies of screening strategies were included if they adequately described the study population and comparison … Included studies used credible reference standards, adequately described the study population, defined … Three studies described additional methodological difficul- ties related to the reference standard (29
  5. www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2008
    August 05, 2008 - at increased risk for diagnosis of and death from prostate cancer. 1 Unfortunately, the previously described … However, the natural history of PSA-detected, nonpalpable, localized prostate cancer is poorly described
  6. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/genital-herpes-screening-november-2016
    August 06, 2015 - The figure is an analytic framework that depicts the seven key questions described in the research plan
  7. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
    August 24, 2017 - c Pretest genetic counseling, scope of services, and appropriate providers are described in the text.
  8. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary21/depression-in-children-and-adolescents-screening-2009
    March 15, 2009 - Therefore, we used a modified approach to reviewing these abstracts as described in  Appendix 2 . … Details of our quantitative synthesis approach and rationale are described in detail in  Appendix 2 . … Nondirective supportive psychotherapy was considered to be a treatment group unless it was described … a USPSTF quality criteria are described in Appendix 4 . … a USPSTF quality criteria are described in Appendix 4 .
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening-january-2017
    January 24, 2017 - The USPSTF reviewed evidence from 76 good- to fair-quality treatment trials that described the effect … In response to comments, the USPSTF described common symptoms of OSA and defined what is meant by persons … Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org
  10. www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-blood-pressure-in-adults-screening-monitoring-october-2015
    October 12, 2015 - Implementation Screening for high blood pressure may be done in the office setting by using the proper methods described … USPSTF recommends rescreening with adequate office blood pressure measurement using the techniques described … Authors followed the policy regarding conflicts of interest described at www.uspreventiveservicestaskforce.org
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zHvENvrSUeZh6gFPUK_37c
    February 13, 2018 - The CA-125 ROCA screening in- tervention group was described as multimodal screening in the trial publications … Screening The USPSTF reviewed evidence on harms of screening for ovarian cancer from the 3 studies described … Authors followed the policy regarding conflicts of interest described at https: //www.uspreventiveservicestaskforce.org
  12. www.uspreventiveservicestaskforce.org/uspstf/specific-populations
    June 01, 2018 - Specific Populations Share to Facebook Share to X Share to WhatsApp Share to Email Print The U.S. Preventive Services Task Force (USPSTF) is committed to improving the health of people nationwide. The USPSTF makes evidence-based recommendatio…
  13. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/behavioral-counseling-interventions-evidence-based-approach
    March 04, 2021 - necessarily varies from behavior to behavior, but clinical intervention targeting any behavior change can be described … change, whether the behavior is being added or deleted, and by factors individual to the patient, as described
  14. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-3-topic-work-plan-development
    June 22, 2025 - Work plan development for topic reaffirmation updates is described in Section 4.7 . … The template for the work plan is described below and in Appendix V .
  15. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
    December 15, 2013 - Studies of any design were included if they described potential adverse effects, including inaccurate … No studies described adverse effects of the risk models. … Five studies that enrolled mutation carriers and other high-risk women described adverse effects 91- … Adverse effects were described in a study of annual measurements of serum cancer antigen-125 (CA-125) … Few studies described adverse effects.
  16. www.uspreventiveservicestaskforce.org/uspstf/recommendation/rhd-incompatibility-screening-1996
    January 01, 1996 - incidence of D isoimmunization, from 13-14% in the mid-1960s to 1-2% in the mid-1970s, 7 , 17 although as described … induced abortion, isoimmunization occurred in 0.4%, 29 compared to 2.6% among a series of patients, described
  17. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-women-and-elderly-adults/intimate-partner-violence-and-elderly-abuse-screening-2004
    March 08, 2004 - included in this review had English-language abstracts; were applicable to U.S. clinical practice; described … Included studies described the study sample, the screening instrument or procedure, the abuse or neglect … Screening instruments are described in Appendix 3 . 49-61 Six studies compared brief screening instruments … Two studies described screening elderly adults. … Diagnostic Accuracy Studies Criteria: Screening test relevant, available for primary care, adequately described
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/SvB6EjoVaaQxQr4vpCRtWp
    March 01, 2004 - included in this review had English-language abstracts; were applicable to U.S. clinical practice; described … Included studies described the study sample, the screening instrument or procedure, the abuse or neglect … Screening instruments are described in Appendix 3.49–61 Six studies compared brief screening instruments … Two studies described screening elderly adults. … Diagnostic Accuracy Studies Criteria: • Screening test relevant, available for primary care, adequately described
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/h8qcZeQ68AQPS9DemArgXX
    July 13, 2021 - Per the ADA recommendations, the test should be performed as described by the World Health Organization … Two RCTs (described in 5 articles) conducted in the UK evalu- ated invitations to screening for diabetes … One cluster RCT (ADDITION-Europe, described in 8 articles15,75-80,103) that evaluated interventions … This review included 5 RCTs (described in 8 articles) evaluat- ing interventions for recently diagnosed … Four RCTs (described in 6 articles) reported on harms of interventions for screen-detected or recently
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/mggnaKHr496c8QCgHe9-tm
    May 01, 2021 - harms of bronchodilators and ICS in the treat- ment of COPD, such as heart failure and pneumonia, as described … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: